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Abstract 
Objectives To test the hypothesis that bacterial infections in pregnancy are related to 
maternal blood pressure. Study Design Bacterial infection was assessed using antibiotic 
usage as a surrogate and its association with blood pressure in pregnancy tested in the 
Cambridge Baby Growth Study. Main Outcome Measures Antibiotic usage in pregnancy was 
self-reported in questionnaires. Blood pressure measurements at four time points in 
pregnancy were collected from the hospital notes of 622 women. Results Using all the 
available blood pressure readings (adjusted for weeks gestation) antibiotic usage was 
associated with a higher mean arterial blood pressure across pregnancy: antibiotics used 85 
(84, 87) mmHg v. no antibiotics used 83 (83, 84) mmHg (β = 2.3 (0.6, 4.0) mmHg, p = 9.6 x 
10-3, from 621 individuals). Further analysis revealed that antibiotic usage was associated 
with diastolic (β = 2.3 (0.6, 4.0) mmHg; p = 7.0 x 10-3) more than systolic blood pressure (β = 
1.4 (-0.9, 3.7) mmHg; p = 0.2). The effect size associated with antibiotic usage appeared to 
rise slightly after the first trimester. Conclusions Bacterial infection in pregnancy, as 
assessed by self-reported antibiotic usage, is associated with small rises in blood pressure. 
 
Key words: gestational hypertension; pre-eclampsia; antibiotics; pregnancy 
 
  
Petry et al., page - 3 - 
 
Introduction 
Pre-eclampsia remains a leading cause of maternal and perinatal mortality and morbidity. 
Its established risk factors include null parity, maternal age > 40 years, multiple pregnancy, 
extended times between pregnancies, the presence of antiphospholipid antibodies, prior 
pre-eclampsia in a previous pregnancy or a positive family history, chronic hypertension or 
gestational hypertension during pregnancy, pre-gestational or gestational diabetes, obesity 
and use of assisted reproductive technology [1, 2]. Less established potential risk factors 
include infection [3] and consequences of infection such as inflammation. Indeed the usual 
inflammatory response observed in uneventful pregnancies is enhanced in pregnancies 
affected by pre-eclampsia [4]. It has been suggested that the link between infection and the 
development of pre-eclampsia could be at the level of its initiation, due to an increased risk 
of uteroplacental atherosis (fibrinoid necrosis of the vessel wall with subintimal 
accumulations of lipophages), and/or its progression, through an increase in the maternal 
inflammatory response during pregnancy [5]. 
 
A number of studies have sought associations between infections in pregnancy and the 
development of pre-eclampsia. Whilst not all studies have found significant associations [3], 
most have found a positive association, as supported by subsequent meta-analyses [6, 7]. 
Less is known about potential links between infections and less severe rises in blood 
pressure in pregnancy. To investigate this we studied antibiotic usage in pregnancy as a 
surrogate of bacterial infection exposure, plus urinary tract infection (UTI) exposure (the 
commonest form of bacterial infection in pregnancy), to test the hypothesis that bacterial 
infection in pregnancy is associated with rises in blood pressure. 
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 Materials and Methods 
Cohort 
The prospective and longitudinal Cambridge Baby Growth Study recruited 2,229 mothers 
(and their partners and offspring) attending ultrasound clinics during early pregnancy at the 
Rosie Maternity Hospital, Cambridge, United Kingdom, between 2001 and 2009 [8]. All 
study participants were over 16 years of age and for this study, women who took anti-
hypertensive drugs were excluded. Participants who may have had raised blood pressure at 
certain points during the pregnancy, e.g. during labour, but who did not report anti-
hypertensive usage were still included in the study. Fasting blood samples were collected 
from 1,239 participants for the measurement of plasma glucose and insulin concentrations 
around week 28 of pregnancy for the evaluation of insulin sensitivity by Homeostasis Model 
Assessment (HOMA) modelling [9]. In this cohort, 96.9% of the offspring were of white 
ethnicity, 0.8% were of mixed race, 0.6% were black (African or Caribbean), 0.8% were East-
Asian, and 0.9% were Indo-Asian. 
 
Antibiotic Usage 
Each of the study participants were given a printed questionnaire at recruitment to fill in 
and return once the pregnancy was completed [10]. One of the questions asked “Have you 
taken any medicine during this pregnancy?” Those women who responded in the 
affirmative were then asked to complete a table with the following headings: “Name”, 
“Disease”, “Daily Dose”, “No. of Days” and “Gestational Week(s)”. From these 
questionnaires drugs were categorised into three major dichotomous groups: paracetamol-
containing drugs, drugs used to treat indigestion and antibiotics. No account was taken of 
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the number of times that a particular drug was taken, the specific drug that was taken or 
the doses consumed. 
 
For the purposes of this study only the category based on antibiotic usage was employed. 
The timings when the antibiotics were reported having been taken were divided into 
trimesters (first trimester being up to gestational week 12, second trimester being weeks 13 
to 27 and third trimester being from week 28 onwards). Of the 1,271 women that filled out 
questionnaires, 173 (13.6 %) reported that they had taken antibiotics during pregnancy and 
1,098 had not. Of the women that reported having taken antibiotics in pregnancy 51 
reported first trimester usage, 68 second trimester and 54 third trimester (some women did 
not specify the timing when they took antibiotics, whereas some of the others reported 
taking them in more than one trimester). Specific antibiotic usage was reported as follows: 
amoxycillin (71 women), cephalexin/cefalexin (16), penicillin (16), erythromycin (15), 
flucloxacillin (6), clarithromycin (3), augmentin (2), cephradine (2), ampicillin (1), cefaclor 
(1), cefotaxime (1), ciproflaxine (1), metronidazole (1), trimerthoprim (1) and ‘antibiotic(s)’ 
(37).  
 
Urinary Tract Infections 
The most common reason given for taking antibiotics during pregnancy was to treat UTIs. Of 
the 1,271 women that filled out their questionnaires, 53 (4.2 %) self-reported that they had 
experienced UTIs at some point during their pregnancy. Of these women 19 reported having 
had UTIs in the first trimester of pregnancy, 25 in the second trimester and 14 in the third 
trimester; some women reported having had UTIs in more than one trimester and some did 
not disclose when in pregnancy they were infected. 
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Blood Pressure during Pregnancy 
Routine blood pressure measurements during pregnancy that had been recorded in hospital 
notes were collected from a total of 968 women in the Cambridge Baby Growth Study 
(other hospital notes either not being available to us or the blood pressures not being 
recorded in the notes) [8]. They were grouped into one of four readings according to the 
gestational week at which the measurements were taken: (1) at 11.8 (11.5, 12.0) weeks, (2) 
at 31.4 (31.3, 31.5) weeks and (3) at 37.0 (36.9, 37.0) weeks. The fourth readings were taken 
during the final 2 weeks prior to parturition (mean 38.8 weeks), parturition occurring at 39.8 
(39.7, 39.9) weeks. Blood pressure measurements were available from 622 women for 
whom self-reported antibiotic usage was available (84 (13.5 %) of whom had taken 
antibiotics during pregnancy). The characteristics of those who we had blood pressure 
readings for, according to whether they took antibiotics or not are shown in Table 1. There 
were no significant differences between the groups, although the pre-pregnancy BMI was 
borderline higher in those who subsequently took antibiotics. In those women where we 
had blood pressure readings 27 (4.3 %) reported that they had had at least one UTI during 
their pregnancy.  
 
Ethics 
The Cambridge Baby Growth Study was approved by the local ethics committee, 
Addenbrooke’s Hospital, Cambridge, United Kingdom. All procedures followed were in 
accordance with the institutional guidelines. Written informed consent was obtained from 
all the study participants. 
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Assays 
Blood glucose concentrations were measured using a routine glucose oxidase-based 
method. Plasma insulin concentrations were measured using a DSL ELISA kit (London, U.K.) 
according to the manufacturer’s instructions. 
 
Calculations 
Mean arterial blood pressure was estimated as twice the diastolic plus the systolic blood 
pressure all divided by three. The body mass index (BMI) before pregnancy was calculated 
as the pre-pregnancy body weight divided by the height squared. HOMA S was calculated 
using the online calculator available at https://www.dtu.ox.ac.uk/homacalculator/ [9]. 
 
Statistical Analysis 
The associations between antibiotic usage (or UTI) at any time during pregnancy and blood 
pressure (mean arterial, systolic or diastolic) were tested using general estimation equation 
modelling, adjusting for weeks of gestation (and sometimes BMI) when the blood pressure 
readings were taken. Associations at individual time points and between antibiotic use and 
HOMA S (insulin sensitivity) or between blood pressure and antibiotic use/UTIs in specific 
trimesters were assessed by linear regression. Values for those women that experienced 
UTIs were compared with those from women who did not report any antibiotic usage at all 
(those women who reported antibiotic usage but did not specify why they took antibiotics 
and those that reported other types of infection were removed from the analyses to avoid 
potential confounders). Unless otherwise stated all other data are presented as means (95% 
confidence intervals). Statistical analyses were performed using Stata 13 (StataCorp LP, 
College Station, Texas, U.S.A.). P < 0.05 was considered statistically significant throughout. 
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Results 
Associations between Antibiotic Usage at Any Time during Pregnancy and Blood Pressure 
Antibiotic usage was associated with a higher mean arterial blood pressure in pregnancy as 
a whole, mean arterial blood pressures over the four readings recorded during pregnancy 
being: antibiotics used 85 (84, 87) mmHg v. no antibiotics used 83 (83, 84) mmHg (β = 2.3 
(0.6, 4.0) mmHg, p = 9.6 x 10-3, from 621 individuals) (Fig. 1). Further adjustment for BMI did 
not appreciably change the outcome: antibiotics used 86 (84, 88) mmHg v. no antibiotics 
used 83 (83, 84) mmHg (β = 2.7 (0.4, 5.0) mmHg, p = 0.02, from 434 individuals). 
 
Separating the mean arterial blood pressure into its component systolic and diastolic parts, 
antibiotic usage was not associated with systolic blood pressures over the four readings 
taken over pregnancy:  antibiotics used 115 (113, 117) mmHg v. no antibiotics used 114 
(113, 114) mmHg (β = 1.4 (-0.9, 3.7) mmHg, p = 0.2). Further adjustment for BMI led to even 
more overlap between the two groups: antibiotics used 114 (111, 117) mmHg v. no 
antibiotics used 114 (113, 115) mmHg (β = -0.1 (-3.4, 3.3) mmHg, p = 1.0, from 434 
individuals). Antibiotic usage, however, was associated with diastolic blood pressure over 
the same readings: antibiotics used 70 (69, 72) mmHg v. no antibiotics used 68 (67, 
69) mmHg (β = 2.3 (0.6, 4.0) mmHg, p = 7.0 x 10-3), although further adjustment for BMI 
weakened the relationship as the 95 % confidence interval for the diastolic blood pressures 
of those women who used antibiotics widened: antibiotics used 70 (68, 73) mmHg v. no 
antibiotics used 68 (67, 69) mmHg (β = 2.2 (-0.2, 4.6) mmHg, p = 0.08, from 434 individuals). 
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Associations between Antibiotic Usage in Specific Trimesters of Pregnancy and Blood 
Pressure 
Table 2 shows associations between antibiotic usage in specific trimesters of pregnancy and 
mean arterial blood pressures at time points close to those particular trimesters. Here the 
mean effect size appeared to rise after the first trimester. 
 
Associations with HOMA S (Insulin Sensitivity) 
Each of the blood pressure readings were associated with reduced week 28 HOMA S: week 
11.8 (β’ = -0.216, p = 2.7 x 10-6, n = 465), week 31.4 (β’ = 0.267, p = 4.3 x 10-9, n = 468), week 
37.0 (β’ = -0.303, p = 2.7 x 10-11, n = 458) and week 38.8 (β’ = -0.228, p = 1.8 x 10-5, n = 348). 
However there was no association between antibiotic usage and HOMA S: antibiotics used 
109.4 (99.6, 120.3) %S (n = 123) v. no antibiotics used 109.6 (105.5, 113.8) %S (n = 751) 
(p = 1.0). 
 
Associations with Urinary Tract Infection(s) 
The association between exposure to UTI(s) during pregnancy and overall mean arterial 
blood pressure was not statistically significant: UTI 85 (82, 88) mmHg (n = 27) v. no antibiotic 
use 84 (84, 85) mmHg (n = 516) (β = 0.7 (-2.0, 3.4) mmHg, p = 0.6). Table 3 shows the 
comparison of individual mean arterial blood pressures between those women who 
experienced UTI(s) during pregnancy and those that did not. The effect sizes were positive 
but small and not statistically significant for all the blood pressure associations with UTIs. 
 
Discussion 
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In this study we have shown that in our population self-reported general antibiotic usage in 
pregnancy is associated with a small increase in mean arterial blood pressure of around 
2~3 mmHg. Although infections, such as those requiring treatment with antibiotics, have 
previously been shown to be associated with severe hypertensive disorders of pregnancy [6, 
7], this is the first time that a surrogate of bacterial infections has been shown to be 
associated with raised blood pressure in pregnancy per se. This rise in blood pressure 
appeared to relate to the diastolic more than the systolic blood pressure measurements. 
Those women who reported that they took antibiotics had slightly higher pre-pregnancy 
BMIs than those that did not (there being a borderline statistical rather than a clinical 
difference) but adjusting for this did not change the outcome so the antibiotic-associated 
change in blood pressure did not relate directly to obesity.  
 
Although there appears to be a link between infection and pre-eclampsia [6, 7] less has 
been reported about infection and less severe forms of pregnancy-induced hypertension. 
Two studies showed associations between UTIs and increased risk of gestational 
hypertension [11, 12] whereas another study reported a reduced frequency of non-
proteinuric pregnancy-induced hypertension in women infected with T. gondii [13] 
(explained by long-term antibiotic usage reducing further bacterial infections). Based on 
these studies we believe that our association between raised blood pressure in pregnancy 
and antibiotic usage reflects exposure to bacterial infections of sufficient severity to merit 
treatment. Indeed when testing associations between maternal blood pressures at different 
time points across pregnancy and UTIs, we found effect sizes of 0.4~2.3 mmHg increases in 
mean arterial blood pressure in the infected group (albeit without statistical significance, 
presumably because of insufficient statistical power). We could not detect significant 
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associations when testing specific trimesters of active infection, although again all the effect 
sizes were positive. The largest of these were in the third trimester of pregnancy, when the 
overall effect size associated with all women who took antibiotics during pregnancy was 
actually decreasing (Fig. 1). This was probably due to the effect of including blood pressures 
of women who used antibiotics earlier in pregnancy but who were free of infection by the 
third trimester. 
 
There are a number of other possible explanations to explain the associations between 
antibiotic usage in pregnancy and increases in blood pressure, although they appear to be 
less convincing. Firstly antibiotics could have a direct effect on blood pressure in pregnancy, 
although we do not know of any published evidence of this. Secondly rises in blood pressure 
can sometimes be associated with effects of antibiotic allergy [14], although it seems 
unlikely to have affected our population, due to the infrequency of the allergic reaction 
causing increases in blood pressure [15] and the fact that at the ages of the women studied 
here most of them would probably have avoided taking antibiotics that they knew they 
were allergic to (especially in pregnancy). Thirdly some parenterally-administered antibiotic 
preparations contain sodium [16], intake of which could raise blood pressure. However 
none of the women studied indicated that they received antibiotics by any route other than 
orally. A fourth explanation is that antibiotics could indirectly influence the blood pressure 
through causing changes to the microbiome, as observed in rodent models [17-19]. Whilst 
this is potentially the most plausible alternative explanation for the association between 
antibiotic use in pregnancy and increases in blood pressure [20], there is no evidence for it 
in humans at present and in rodents changes to the microbiome sometimes lead to 
reductions rather than increases in blood pressure [19]. 
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In our study the mechanism behind the raised blood pressure did not appear to involve 
altered insulin sensitivity, despite the established link between insulin resistance and 
hypertensive syndromes of pregnancy [21, 22]. One potential mechanism that is 
independent of changes in insulin sensitivity, however, involves altered endothelial nitric 
oxide synthase (eNOS) activity which regulates vascular tone. In vitro studies of human 
umbilical vein endothelial cells suggest that infectious stimuli are able to lower eNOS gene 
expression [23]. Consistent with this, serum nitric oxide concentrations appear to be 
reduced in pre-eclampsia [24]. Our association between antibiotic usage and rises in blood 
pressure relating more to diastolic rather than systolic blood pressure may also be 
consistent with this given that effects of changes in nitric oxide production would tend to 
affect arterial resistance rather than cardiac output, which comprises a greater part of the 
diastolic than the systolic blood pressure. 
 
Although the results from this study are interesting it does have limitations. Firstly it 
appears underpowered to detect associations with UTIs, with antibiotic usage at specific 
time points and with specific antibiotic usage, especially when the overall rise in mean 
arterial blood pressure in women who took antibiotics in pregnancy was only 2~3 mmHg. 
Another study limitation is that self-reporting prescription drug intakes can be affected by 
recall bias, and recall for drugs with short-term use such as antibiotics may be lower than 
that for drugs used to treat chronic conditions [25]. However recall bias through forgetting 
antibiotic consumption would tend to reduce the effect size rather than increase it. As we 
found a significant association even with potential recall bias our conclusions would not 
change if the bias lessened however. We did not have continuous blood pressure readings 
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from pregnancy and it is possibly that certain study participants may have had raised blood 
pressures at times not specifically analysed in this study, e.g. during labour. However unless 
there was a difference in the occurrence rates of such occasions between our groups, it is 
unlikely to have significantly affected our overall results. Finally it remains possible that the 
significant association arose due to either random variation or microbiome alterations. 
However given the established links between infection and pre-eclampsia [6, 7, 11-13] and 
the fact that there is a potential mechanism available, our interpretation of the primary 
association appears most convincing. 
 
In summary we have shown for the first time that self-reported antibiotic use in pregnancy, 
most likely reflecting bacterial infections of sufficient severity to merit antibiotic treatment, 
is associated with a modest rise in mean arterial blood pressure. Partially consistent with 
our findings, in a study over 6,000 (non-pregnant) women of all ages from the 1960s the 
mean systolic blood pressures of women with significant bacturia were around 3 mmHg 
higher than those without bacturia, although statistical significance was not reached on this 
occasion [26]. Our findings are therefore unlikely to have arisen by chance and although our 
detected effect size on blood pressure is small, the findings underpin published links 
between infection in pregnancy and pre-eclampsia. 
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Table 1 Characteristics of those Cambridge Baby Growth Study participants who reported to 
have taken antibiotics during pregnancy and those that did not in women that we had blood 
pressure readings from.  
Characteristic Women who reported 
taking antibiotics during 
pregnancy 
(n=84) 
Women who did not report 
taking antibiotics during 
pregnancy 
(n=538) 
p-
value 
Maternal age (years) 33.4 
(32.4, 34.4) 
33.6 
(33.3, 34.0) 
0.7 
Parity 1.7 
(1.5, 1.9) 
1.7 
(1.6, 1.8) 
1.0 
Gestational age at 
baby’s birth (weeks) 
39.8 
(39.5, 40.1) 
40.0 
(39.8, 40.1) 
0.4 
Birth weight of baby 
(kg) 
3.530 
(3.433, 3.628) 
3.479 
(3.440, 3.518) 
0.3 
Percentage giving 
birth to males 
51.8 51.3 0.9 
Pre-pregnancy BMI 
(kg/m2) 
24.7 
(23.7, 25.6) 
23.7 
(23.3, 24.1) 
0.06 
Percentage that 
reported smoking 
4.8 2.6 0.3 
Percentage with 
gestational diabetes 
11.7 10.9 0.9 
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The birth weights of the offspring were adjusted for gestational age at birth, sex, parity and 
maternal BMI before pregnancy. 
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Table 2 Mean arterial blood pressures and antibiotic usage in specific trimesters of 
pregnancy (using readings taken close to that specific trimester). 
 
Gestation 
when blood 
pressure was 
recorded 
(weeks) 
Trimester of 
pregnancy 
when 
antibiotics 
were 
reported as 
being used 
Women 
who used 
antibiotics 
(mmHg) 
Women 
who did 
not use 
antibiotics 
(mmHg) 
β 
(mmHg) 
p-value 
11.8 1 80 
(77, 84) 
(n=29) 
80 
(79, 81) 
(n=520) 
0.2 
(-3.1, 
3.5) 
0.9 
11.8 2 82 
(79, 85) 
(n=34) 
80 
(79, 81) 
(n=520) 
1.8 
(-1.2, 
4.9) 
0.2 
31.4 2 84 
(81, 87) 
(n=34) 
81 
(80, 82) 
(n=523) 
2.5 
(-0.5, 
5.6) 
0.1 
31.4 3 84 
(80, 88) 
(n=19) 
81 
(80, 82) 
(n=523) 
3.2 
(-0.8, 
7.3) 
0.1 
37.0 3 87 85 2.7 0.3 
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(83, 92) 
(n=17) 
(84, 86) 
(n=511) 
(-2.0, 
7.4) 
38.8 3 89 
(84, 95) 
(n=16) 
87 
(86, 88) 
(n=405) 
2.7 
(-2.5, 
7.9) 
0.3 
The mean arterial blood pressures were adjusted for the number of weeks gestation when 
the measurements were taken throughout. Data are mean (95 % confidence interval). 
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Table 3 Maternal mean arterial blood pressures in pregnancy and in women who 
experienced UTI(s) during pregnancy compared with those without infection.  
 
Gestation 
(weeks) 
Experienced urinary tract 
infection(s) during pregnancy 
No antibiotic usage 
during pregnancy 
β 
(mmHg) 
p-
value 
11.8 81 
(77, 84) 
(n = 27) 
80 
(79, 81) 
(n = 514) 
0.4  
(-3.0, 
3.8) 
0.8 
31.4 83 
(79, 86) 
(n = 27) 
81 
(80, 82) 
(n = 516) 
1.6 
(-1.9, 
5.0) 
0.4 
37.0 86 
(82, 89) 
(n = 26) 
85 
(84, 86) 
(n = 506) 
0.9 
(-2.9, 
4.8) 
0.6 
38.8 89 
(84, 94) 
(n = 19) 
87 
(86, 88) 
(n = 402) 
2.3 
(-2.4, 
7.1) 
0.3 
The mean arterial blood pressures were adjusted for the number of weeks gestation when 
the measurements were taken throughout. Data are mean (95 % confidence interval).  
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Figure Legend 
Figure 1 Mean arterial blood pressures in women that reported use of antibiotics during 
pregnancy and the women that did not in the Cambridge Baby Growth Study. Data are 
mean (S.E.M.). 
 
